Company
Colossal Biosciences
Colossal is a bioscience and genetics company focused on the field of species de-extinction
Also known as Colossal, Colossal Biosciences Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Austin, TX, United States
- Founded
- 2021
- Legal name
- Colossal Biosciences Inc.
- colossal.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 8 October 2026
About
Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth.
Funding snapshot
- Total raised
- $438MSum of rounds, as of 2026-10-08Source (opens in a new tab)
- Latest round
- Series C, $200M2025-01
Funding rounds
- Series C
- $200M2025-01, Announced, post-money $10.2B
- Series B
- $163M2023-01-27, SEC form D sold, 27 investors
- Series A
- $60M2022-03, Announced
- Seed
- $15M2021-09-13, Announced
Loading relationship preview